News

‘Don’t make ads, make TikToks’: Saatchi report digs into what TikTok users want

The report found that ad engagement on TikTok is quite high, with 56% of users saying they’ve bought products based on TikTok videos.

News

FDA yanks EUA for AstraZeneca’s Evusheld as COVID variants continue to evolve

AstraZeneca said it will continue to work with the FDA and other health authorities to “collect, assess and share relevant data” regarding Evusheld and COVID-19 variants.

News

Neutrogena puts former dating show alums on TikTok reality show

Agency Movers+Shakers talks about capturing Gen Z’s attention for Neutrogena and navigating a saturated skincare market.

Video: Optimizing omnichannel engagement through a single audience.

How real world data can create a more effective media mix for DTC marketing.

How using real world data across channels can better engage healthcare providers and patients

Building custom audience segments to create a more effective media mix.

How data-driven linear unifies TV planning, activation and measurement

Data-driven linear (DDL) represents a tremendous opportunity for health marketers to reach condition-specific patients and spend smarter on TV advertising by optimizing media across channels. Here's what that means for your budget and campaign effectiveness.

Why data-driven linear is the last piece of the marketing puzzle

Reduce waste, optimize media and achieve cross-channel attribution by unifying television.

Partner Content

Getting back to what matters at the Unagency

How a different kind of ad agency prioritizes relationships.

Partner Content

Moving beyond patient engagement, toward patient empowerment

From patient engagement to patient empowerment, Outcomes is moving upstream to give patients control of their prescriptions.

Partner Content

Shining a light on health equity

Campaigns focused on diversity in clinical trials and addressing implicit bias.

Partner Content

Clinical trials and tech: Innovation starts with inclusion

How can technology facilitate inclusion and diversity in clinical trials?